Skip to main content

Why Egypt chose Chinese COVID-19 vaccine over Russian one

As Egypt and China are set to sign an agreement for the distribution of a Chinese coronavirus vaccine, questions arise as to the efficiency of this vaccine.

In this picture taken on April 29, 2020, an engineer takes samples of monkey kidney cells as he make tests on an experimental vaccine for the COVID-19 coronavirus inside the Cells Culture Room laboratory at the Sinovac Biotech facilities in Beijing. - Sinovac Biotech, which is conducting one of the four clinical trials that have been authorised in China, has claimed great progress in its research and promising results among monkeys. (Photo by NICOLAS ASFOURI / AFP) / TO GO WITH Health-virus-China-vaccine,FO
An engineer takes samples of monkey kidney cells for the testing of an experimental vaccine for the coronavirus, inside the Cells Culture Room laboratory at the Sinovac Biotech facilities in Beijing, China, April 29, 2020. — NICOLAS ASFOURI/AFP via Getty Images

CAIRO — The Egyptian government is expected to sign an agreement with its Chinese counterpart later this month for the distribution within four months of a Chinese coronavirus vaccine that is now in its final development stages. 

Egypt has ignored Russian calls for a partnership to produce another coronavirus vaccine. On Aug. 11, Russia became the first country in the world to announce the approval of a COVID-19 vaccine.

Related Topics

Subscribe for unlimited access

All news, events, memos, reports, and analysis, and access all 10 of our newsletters. Learn more

$14 monthly or $100 annually ($8.33/month)
OR

Continue reading this article for free

All news, events, memos, reports, and analysis, and access all 10 of our newsletters. Learn more.

By signing up, you agree to Al-Monitor’s Terms and Conditions and Privacy Policy. Already have an account? Log in